Endothelial function, arterial stiffness and lipid lowering drugs

Konstantinos Tziomalos1, Vasilios G Athyros, Asterios Karagiannis

  • 1University of London, Department of Clinical Biochemistry, Royal Free Hospital, Pond Street, London NW3 2QG, UK.

Insights

Assessing endothelial function and arterial stiffness provides insights into vascular health and cardiovascular risk. This review covers methods to evaluate these markers and the impact of lipid-lowering treatments.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Medical Diagnostics

Background:

  • The endothelium is crucial for maintaining cardiovascular homeostasis.
  • Endothelial dysfunction is an early indicator of atherosclerosis and cardiovascular disease.
  • Assessing endothelial function can serve as a measure of vascular health and cardiovascular risk.

Purpose of the Study:

  • To review methods for assessing endothelium-dependent vasodilatation and their prognostic value.
  • To discuss techniques for evaluating arterial stiffness, a marker influenced by endothelial function.
  • To explore the impact of lipid-lowering therapies on endothelial function and arterial stiffness.

Main Methods:

  • Review of literature on methods for assessing endothelial function (e.g., flow-mediated dilation).
  • Discussion of techniques for measuring arterial stiffness (e.g., pulse wave velocity).
  • Analysis of studies examining the effects of lipid-lowering treatments.

Main Results:

  • Various methods exist to assess endothelial function, with prognostic implications for cardiovascular risk.
  • Arterial stiffness evaluation is a significant area of research linked to endothelial health.
  • Lipid-lowering treatments can positively influence both endothelial function and arterial stiffness.

Conclusions:

  • Endothelial function and arterial stiffness are key indicators of vascular health.
  • Accurate assessment methods are vital for gauging cardiovascular risk.
  • Therapeutic interventions targeting lipids may improve endothelial health and reduce arterial stiffness.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...